This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print page

Life Sciences & Health Care

Shifting demographics. Shrinking margins. Evolving regulations. Rising R&D costs. There is little doubt that life sciences and healthcare companies face a significant range of challenges for the years ahead. To adapt effectively, these organisations must re-examine their underlying operational strategies and refine their business models.

With experience in working with life sciences and healthcare companies to navigate multiple complex regulatory and financial ecosystems and optimise marketing and distribution channels, Deloitte's professionals are able to help our clients improve their business processes and achieve effective compliance in order to strengthen both patient care and stakeholder value.

More Featured insights

  • 2014 Global health care outlook
    The global health care industry is undergoing a period of “glocalization,” a term that combines “globalization” and “localization” to describe the adaptation of global products or services to accommodate the needs of people in a specific locale.
  • 2014 Global life sciences outlook
    Despite heightened regulatory scrutiny, continued pricing pressures and another year of impacts from health care reform in many countries, the global life sciences sector is exhibiting resilience and reinvention.
  • Healthcare 3.0: Healthcare for the new normal
    The human body is a complex system which owes its continued survival to its individual component organs working independently and, simultaneously, in unison within a fully integrated and self-regulated environment. Launched at the 2nd Malaysia International Healthcare Travel Expo (MIHTE 2013), the latest Deloitte report Healthcare 3.0: Healthcare for the new normal suggests that healthcare systems for the new normal should strive to work in a similar cohesive manner.

Contact our leader

Mohit Grover
Southeast Asia & Malaysia Industry Leader
Life Sciences & Health Care

Learn more

  • ExternalURL
    Zero to Hero
    How Deloitte helped a pharma company start up global operations to deliver a potentially life-saving antiviral
  • ExternalURL
    Health Care industry megatrends
    A Deloitte Center for Health Solutions discussion
  • ExternalURL
Stay connected:
More on Deloitte
Learn about our site